Astellas Pharma Inc. 13D and 13G filings for Taysha Gene Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-18 5:16 pm Purchase | 2023-08-16 | 13D | TAYSHA GENE THERAPIES INC TSHA | Astellas Pharma Inc. | 7,266,342 3.890% | 7,266,342 (New Position) | Filing |